8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2016 / Open-label prospective uncontrolled study
An open-label prospective study prescribed vitamin D at 5000 IU/day during pregnancy to mothers of children with autism, and 1000 IU/day to newborn siblings until their third birthday. Followed for three years and assessed at 18 and 36 months, 1 out of 19 (5%) newborn siblings developed autism, compared to an approximate 20% recurrence rate in the literature. The authors note the study is preliminary, had very small numbers, lacked blinding, and had no control group.
Stubbs G, Henley K, Green J Med Hypotheses, 2016. PMID 26880644
2016 / Nutritional intervention study (before-and-after)
A nutritional intervention study evaluated the effect of consuming 200 g/day of açai pulp for 4 weeks in 35 healthy women. Following açai intake, catalase activity and total antioxidant capacity increased, while the production of reactive oxygen species was reduced. Furthermore, serum concentrations of protein carbonyl decreased and total serum sulfhydryl groups increased.
Barbosa PO, Pala D, Silva CT, et al. Nutrition, 2016. PMID 26883870
2016 / Randomized, double-blind pilot trial
A randomized, double-blind pilot study evaluated the therapeutic role of vitamin B12 in 40 chronic tinnitus patients. Group A (20 patients) received weekly intramuscular vitamin B12 (2500 mcg) for 6 weeks, while Group B (20 patients) received placebo isotonic saline. Vitamin B12 deficiency (<250 pg/ml) was observed in 17 of 40 patients (42.5%). Among patients in Group A with vitamin B12 deficiency, paired t-tests showed significant improvement in mean tinnitus severity index scores and visual analog scale scores after vitamin B12 therapy.
Singh C, Kawatra R, Gupta J, et al. Noise Health, 2016. PMID 26960786
2016 / Multicenter randomized controlled trial
Healthy, non-obese participants were randomized 2:1 to 25% caloric restriction or an ad-libitum diet for two years. Overall adverse event rates did not differ significantly between arms, with zero deaths and one serious adverse event reported during caloric restriction. However, participants assigned to caloric restriction developed significantly lower bone mineral density at the lumbar spine, total hip, and femoral neck at 12 and 24 months.
Romashkan SV, Das SK, Villareal DT, et al. Oncotarget, 2016. PMID 26992237
2016 / Pilot nutritional intervention
In a pilot nutritional intervention, 25 healthy subjects (mean age 38.3) consumed 12 Nocellara del Belice green table olives daily for 30 days. Results showed a significant variation in malondialdehyde and a significant decrease in interleukin-6 levels. Additionally, a reduction of fat mass with an increase of muscle mass was observed, whereas no statistically significant differences were found in fecal Lactobacilli concentrations despite a trend toward an increase. The authors caution that these preliminary findings must be verified in a larger sample.
Accardi G, Aiello A, Gargano V, et al. Immun Ageing, 2016. PMID 27053940
2016 / Randomized placebo-controlled trial
Researchers evaluated a four-ingredient nutritional mixture (GSK2890457) in rodent models and a six-week randomized trial with healthy participants and adults with type 2 diabetes. In diabetic participants taking liraglutide, the supplement did not lower weight and produced slight decreases in mean glucose and HbA1c compared to placebo. In those taking metformin, weight increased by 1.26%, while mean glucose and HbA1c were decreased slightly versus placebo.
Hodge RJ, Paulik MA, Walker A, et al. PLoS One, 2016. PMID 27093610
2016 / Multicenter randomized controlled trial
In a multisite trial, 218 healthy nonobese adults were randomized to 2 years of 25% calorie restriction or ad libitum intake. The calorie restriction group lost 7.6 kg versus 0.4 kg in controls (P < 0.001). Compared to controls, calorie restriction improved depressive symptoms, tension, general health, and sexual drive at month 24, as well as sleep duration at month 12 (all P < 0.05), with no adverse quality-of-life effects.
Martin CK, Bhapkar M, Pittas AG, et al. JAMA Intern Med, 2016. PMID 27136347
2016 / Randomized crossover trial
Twenty healthy nonobese men completed an fMRI food picture evaluation task after consuming control inulin or inulin-propionate ester in a randomized crossover design. Increasing colonic propionate reduced the blood oxygen level-dependent signal in the caudate and nucleus accumbens, with the caudate reduction driven specifically by a decreased response to high-energy food. These effects were accompanied by lower subjective appeal of high-energy food pictures and reduced ad libitum energy intake, without changes in plasma PYY, GLP-1, glucose, or insulin.
Byrne CS, Chambers ES, Alhabeeb H, et al. Am J Clin Nutr, 2016. PMID 27169834
2016 / Comparative tissue analysis and animal intervention study
Investigators compared hepatic NAD(+) and NAD(+) biosynthesis enzymes in middle-aged and aged mice and patients, and tested the effects of high-fat diet and nicotinamide riboside in DN-NAMPT transgenic mice. Hepatic NAD(+) levels decreased in aged mice and humans, with compromised NAMPT-controlled NAD(+) salvage. Middle-aged DN-NAMPT mice fed normal chow displayed systemic NAD(+) reduction and moderate NAFLD phenotypes, which deteriorated under a high-fat diet. Oral administration of nicotinamide riboside completely corrected these NAFLD phenotypes.
Zhou CC, Yang X, Hua X, et al. Br J Pharmacol, 2016. PMID 27174364
2016 / Randomized controlled trial
In a randomized, double-blind, placebo-controlled study, 34 adults consumed 510 mg of cholesterol daily alongside 5 g per day of Chlorella or placebo for 4 weeks. Chlorella supplementation led to significantly smaller increases in total cholesterol (3.5% versus 9.8%, P = 0.037) and LDL-C (1.7% versus 14.3%, P = 0.012) compared to placebo. HDL-C increased by 8.3% with Chlorella versus 3.8% with placebo.
Kim S, Kim J, Lim Y, et al. Nutr J, 2016. PMID 27177615
2016 / Before-and-after intervention study
Thirty-six battery manufacturing workers aged 20-60 years received 500 mg/day of vitamin C tablets for one month. Blood lead levels were not significantly altered following supplementation. However, serum lipid peroxide (-15.56%, p<0.001) and serum nitrite (-21.37%, p<0.001) decreased significantly, while erythrocyte superoxide dismutase (38.02%, p<0.001) and catalase (32.36%, p<0.001) increased significantly.
Ghanwat G, Patil AJ, Patil J, et al. J Clin Diagn Res, 2016. PMID 27190789
2016 / Randomized controlled trial
Nineteen healthy adults completed a 4-day inpatient protocol under dim light conditions and were randomized to 3 hours of blue-enriched light exposure either 0.5 hours after waking (n=9) or 10.5 hours after waking (n=10) on Day 3, with Day 2 serving as baseline. In both groups, insulin total area, HOMA-IR, and HOMA-IR AUC were increased, and subjective sleepiness was reduced with blue-enriched light compared to dim light. The evening group, but not the morning group, exhibited a significantly higher peak glucose value during blue-enriched light exposure compared to dim light. There were no other significant differences between morning and evening groups in response to blue-enriched light.
Cheung IN, Zee PC, Shalman D, et al. PLoS One, 2016. PMID 27191727
2016 / Retrospective analysis of a dietary intervention study
Researchers retrospectively analyzed data from 37 adults with metabolic syndrome who consumed 100 g of white button mushrooms daily for 16 weeks, followed by a one-month mushroom-free period. At 16 weeks, participants showed a doubling of serum ergothioneine, increases in ORAC and adiponectin, and significant decreases in carboxymethyllysine (CML) and methylglyoxal (MG). No changes were observed in 8-isoprostane, leptin, or measures of insulin resistance or glucose metabolism. The authors noted that well-controlled studies are needed to confirm these findings.
Calvo MS, Mehrotra A, Beelman RB, et al. Plant Foods Hum Nutr, 2016. PMID 27193019
2016 / Randomized controlled trial
In two randomized controlled trials, 55 overweight and obese adults consumed test meals containing varying mycoprotein amounts (44 g, 88 g, or 132 g) or isoenergetic chicken. High mycoprotein decreased subsequent ad libitum energy intake by 10% (280 kJ / 67 kcal, P=0.009) relative to chicken. All mycoprotein meals reduced postprandial insulin concentrations (incremental AUC drops of 8%, 12%, and 21%, P=0.004), without altering glucose, GLP-1, PYY, or energy expenditure.
Bottin JH, Swann JR, Cropp E, et al. Br J Nutr, 2016. PMID 27198187
2016 / Randomized crossover trial
Eleven healthy normal-weight women completed a crossover trial comparing two 14-day isoenergetic diets consumed in regular (6 meals daily) or irregular (3-9 meals daily) patterns. Regular meal timing produced a significantly greater thermic effect of food (P < 0.05) and reduced glucose incremental area under the curve following a test drink and selected meals. Participants also reported lower hunger and greater fullness ratings during the regular intervention.
Alhussain MH, Macdonald IA, Taylor MA Am J Clin Nutr, 2016. PMID 27305952
2016 / Randomised controlled cross-over trial
A randomized controlled cross-over trial in 20 overweight or obese adults with metabolic abnormalities compared the postprandial effects of two isoenergetic high-fat meals: one with Cheddar cheese and one with a vegan alternative, separated by a 1- to 2-week washout. Postprandial TAG concentrations rose steadily following both meals (P < 0.05) through 6 hours. The incremental AUC (iAUC) for CRP was significantly lower (P < 0.05) following the cheese meal compared with the vegan alternative, though no treatment effect was observed for other inflammatory markers.
NANO counterpoint →
Demmer E, Van Loan MD, Rivera N, et al. J Nutr Sci, 2016. PMID 27313852
2016 / Randomized crossover trial
Eight overweight or obese men completed a randomized crossover trial comparing 24 hours of severe energy restriction (25% of energy needs) against energy balance (100%). Ad libitum energy intake did not differ between conditions on day 2 (15,251 kJ vs 14,946 kJ; P=0.623), day 3, or both days combined. Aside from higher post-breakfast NEFA, GIP, and fat oxidation, hormonal appetite markers and day 2 appetite ratings remained unchanged.
Clayton DJ, Creese M, Skidmore N, et al. Int J Obes (Lond), 2016. PMID 27339607
2016 / Randomized controlled trial and animal study
A randomized controlled trial in humans demonstrated that a moderate protein-restricted diet improved markers of metabolic health. In parallel animal experiments, mice provided a diet specifically low in branched-chain amino acids showed improvements in glucose tolerance and body composition comparable to whole protein restriction. These changes operated through distinct metabolic pathways, indicating that dietary amino acid composition directly influences metabolic function.
Fontana L, Cummings NE, Arriola Apelo SI, et al. Cell Rep, 2016. PMID 27346343
2016 / Inpatient sequential-diet feeding study
Seventeen overweight or obese men resided in metabolic wards and consumed a high-carbohydrate diet for four weeks, followed by four weeks on an isocaloric ketogenic diet. Chamber energy expenditure increased by 57 ± 13 kcal/d (P = 0.0004) and doubly labeled water expenditure rose by 151 ± 63 kcal/d (P = 0.03). However, loss of body fat slowed, and participants lost fat-free mass alongside higher protein utilization.
Hall KD, Chen KY, Guo J, et al. Am J Clin Nutr, 2016. PMID 27385608
2016 / Randomized controlled trial
In the HPS2-THRIVE trial, 25,673 participants aged 50 to 80 years with prior cardiovascular disease receiving statin therapy were randomized to 2 g extended-release niacin with 40 mg laropiprant daily or placebo for 4 years. Participants assigned to niacin-laropiprant experienced non-significantly lower survival (0.012 fewer years [SE 0.007]), significantly fewer quality-adjusted life years (0.023 [SE 0.007] fewer using UK EQ-5D; 0.020 [SE 0.006] fewer using US EQ-5D), and higher hospital costs (UK £101 [SE £37]; US $145 [SE $53]). Stroke, heart failure, musculoskeletal, gastrointestinal, and infection events were associated with substantial declines in quality of life and increased hospital costs.
Kent S, Haynes R, Hopewell JC, et al. Circ Cardiovasc Qual Outcomes, 2016. PMID 27407053
2016 / Randomized, double-blind crossover trial
Six overweight/obese men underwent two experimental periods with endoscopically placed catheters for distal and proximal colonic infusions of sodium acetate (100 or 180 mmol/l) or placebo across fasting and postprandial conditions. Distal colonic 180 mmol/l acetate infusions significantly increased fasting fat oxidation (1.78±0.28 vs. -0.78±0.89 g fat 2 h-1, P=0.015), fasting PYY (P=0.01), and postprandial glucose and insulin levels (P<0.05) compared to placebo. Distal 100 mmol/l acetate tended to decrease fasting TNF-α (P=0.067). In contrast, proximal colonic acetate infusions had no observed effects on substrate metabolism, circulating hormones, or inflammatory markers.
van der Beek CM, Canfora EE, Lenaerts K, et al. Clin Sci (Lond), 2016. PMID 27439969
2016 / Randomized controlled crossover study and in vitro fermentations
Researchers developed inulin short-chain fatty acid esters to deliver propionate directly to the colon and tested them in vitro and in humans. In a randomized controlled crossover study, participants received 10 g/day of IPE-27, IPE-54, or inulin control for 7 days. In vivo, IPE-27 produced greater 13C recovery in breath CO2 than IPE-54 (64.9 vs. 24.9%, P = 0.001) and reduced energy intake during an ad libitum test meal compared with inulin (439.5 vs. 703.9 kcal, P = 0.025) and IPE-54 (439.5 vs. 659.3 kcal, P = 0.025). Intake with IPE-54 did not differ significantly from inulin control.
Polyviou T, MacDougall K, Chambers ES, et al. Aliment Pharmacol Ther, 2016. PMID 27464984
2016 / Double-blind, randomized, placebo-controlled trial
Twenty sedentary adults aged ~50 were randomized to consume 20 g of dark chocolate or placebo daily for 3 months, with 17 completing the study. In the dark chocolate group (n = 9), VO2 max showed a 17% increase (p = 0.056) and maximum work achieved increased significantly (p = 0.026), alongside higher HDL (p = 0.005) and decreased triglycerides (p = 0.07), with no changes in placebo (n = 8). Skeletal muscle showed significant increases in LKB1, AMPK, and PGC1α proteins and their active forms, citrate synthase activity, and reduced glutathione, as well as decreased protein carbonylation, without changes in mitochondrial density. The authors note larger clinical studies are warranted to confirm these observations.
Taub PR, Ramirez-Sanchez I, Patel M, et al. Food Funct, 2016. PMID 27491778
2016 / Intervention study (mice and humans)
Investigators studied the effects of dietary protein dilution (DPD) on metabolic health markers in mice and humans, as well as its mechanistic pathways in murine models. DPD increased serum markers of metabolic health in both mice and humans. In lean mice, DPD promoted metabolic inefficiency by increasing carbohydrate and fat oxidation, and in murine models of obesity, it prevented and curtailed impaired glucose homeostasis independently of obesity and food intake. The metabolic improvements required liver-derived FGF21, induced by liver-integrated stress response-driven NUPR1 triggered by insufficiency of select nonessential amino acids.
Maida A, Zota A, Sjøberg KA, et al. J Clin Invest, 2016. PMID 27548521